Results 141 to 150 of about 13,127 (167)

The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus. [PDF]

J Virol
Zhang R, Jian X, Zhang Y, Sun Y, Xu M, Cao J, Tian G, Xiang L, Shen J, Xiao G, Hu T, Zhang L.   +11 more
europepmc   +1 more source

Infection à hantavirus. [PDF]

CMAJ
Oberweis ML, Blanchard AC, Vaugon E.
europepmc   +1 more source

KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication. [PDF]

J Virol
Hui X, Tian X, Xue C, Ding S, Cui J, Sun A, Lu W, Lou Y, Qian S, Zhao T, Duan L, Wang H.   +11 more
europepmc   +1 more source

Hantavirus. [PDF]

CMAJ
Oberweis ML, Blanchard AC, Vaugon E.
europepmc   +1 more source

Differentiated Contact Tracing for Emerging Zoonotic Hantavirus and Ebolavirus Infections: Lessons from the 2026 Andes Virus (MV Hondius) and Bundibugyo Virus Outbreaks. [PDF]

Viruses
Broccolo F, Galdiero M.
europepmc   +1 more source

How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19. [PDF]

Clin Transl Sci
Ben Ghezala I, Peiffer-Smadja N, Solas C, Nougairède A, Touret F, Bardou M.   +5 more
europepmc   +1 more source

Favipiravir as a potent inhibitor of Newcastle disease virus: <i>in ovo</i> efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition. [PDF]

Vet World
Soomro NA, Nizamani ZA, Tariq M, Kalhoro NH, Mushtaq M.   +4 more
europepmc   +1 more source

Glycemic Alterations in Hospitalized COVID-19 Patients: Hyperglycemia and Newly Detected Diabetes. [PDF]

Epidemiologia (Basel)
Budihoi AA, Nasui B, Roșioară AI, Ciuciuc N, Vesa S, Calinici T, Popa M.   +6 more
europepmc   +1 more source

Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells

Toxicology Letters, 2022
Favipiravir (T-705), used against influenza viruses, is approved for emergency use in many countries for the treatment of COVID-19. The frequent adverse effects of favipiravir are related with the gastrointestinal system, however, studies suggest a ...
Gül Özhan, Tuğçe Boran
exaly   +2 more sources

Ebola virus dynamics in mice treated with favipiravir [PDF]

Antiviral Research, 2015
International audienceThe polymerase inhibitor favipiravir is a candidate for the treatment of Ebola virus disease. Here, we designed a mathematical model to characterize the viral dynamics in 20 mice experimentally infected with Ebola virus, which were ...
Vincent Madelain, Xavier de Lamballerie, Frederik Graw   +2 more
exaly   +2 more sources